Company / Operating Income per Share
Haemonetics Operating Income per Share History
FY2017-FY2026 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
$3.42
FY2026
5-year range
$3.03 / $4.40
FY2022-FY2026
Trend
-
vs FY2025
Sector context
#51 of 154
Health Care
What the data says
At $3.42, Haemonetics's operating income per share ranks #51 of 154 in the Health Care sector. Operating Income per Share has fluctuated over the past 9 years, ranging from $1.10 in FY2017 to $4.40 in FY2024.
Based on SEC 10-K filings.
3.42 in FY2026 with a 5-year CAGR of +16.8%.
Improved from $3.21 to $3.42 over the past 3 years.
Health Care sector context is included.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- +2.2%
- 5-Year CAGR
- +16.8%
- 10-Year CAGR
- -
Sector benchmark
#51 of 154 in Health CareTop 33% of 154This company $3.42 Sector average $4.25
▼
-19.6% below sector average
Key checks
Key Insights
- Ranks #51 out of 154 companies in the Health Care sector.
- Peak operating income per share was recorded in FY2024.
- Lowest operating income per share in the period was in FY2017.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2026 | $3.42 | - |
| FY2025 | - | - |
| FY2024 | $4.40 | +37.1% |
| FY2023 | $3.21 | +5.7% |
| FY2022 | $3.03 | +93.0% |
| FY2021 | $1.57 | -10.1% |
| FY2020 | $1.75 | -12.3% |
| FY2019 | $1.99 | +24.8% |
| FY2018 | $1.60 | +45.0% |
| FY2017 | $1.10 | +394.0% |
As of FY2026 · SEC 10-K · Updated Jun 30, 2026